Skip to main navigation Skip to search Skip to main content

Clinical activity and cardiac tolerability of non-pegylated liposomal doxorubicin in breast cancer: A synthetic review

  • Mario Airoldi
  • , Dino Amadori
  • , Sandro Barni
  • , Saverio Cinieri
  • , Sabino De Placido
  • , Angelo Di Leo
  • , Alessandra Gennari
  • , Stefano Iacobelli
  • , Maria Teresa Ionta
  • , Vito Lorusso
  • , Marzia Lotrionte
  • , Paolo Marchetti
  • , Rodolfo Mattioli
  • , Giorgio Minotti
  • , Paolo Pronzato
  • , Giovanni Rosti
  • , Carlo Alberto Tondini
  • , Andrea Veronesi

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)690-692
Number of pages3
JournalTumori
Volume97
Issue number6
DOIs
Publication statusPublished - Nov 2011
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Breast cancer
  • Non-pegylated liposomal doxorubicin

Cite this